Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jay Schneider

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Activities & Behaviors

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Rothblat, DS
11
Decamp, Emmanuel
10
Lidsky, Theodore
8
Guilarte, Tomás
7
Anderson, David
7
Syversen, Tore
6
Schroeder, Joseph
5
Roeltgen, David
5
Tinker, JP
5
Wade, Timothy
4
Van Velson, M
4
Wade, T
4
Lloyd, Kenneth
4
Markham, Charles
4
Menzaghi, Frédérique

Sign-in to see all Coauthors

Publications

TOP 3
Burton Neal C; Schneider Jay S; Syversen Tore; Guilarte Tomás R
Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain.
Yang Chengwu; Garrett-Mayer Elizabeth; Schneider Jay S; Gollomp Stephen M; Tilley Barbara C
Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
Decamp E; Schneider J S
Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jay Schneider (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Burton Neal C; Schneider Jay S; Syversen Tore; Guilarte Tomás R
Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain.
Toxicological sciences : an official journal of the Society of Toxicology 2009;111(1):131-9.
2009: Yang Chengwu; Garrett-Mayer Elizabeth; Schneider Jay S; Gollomp Stephen M; Tilley Barbara C
Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(10):1453-60.
2009: Decamp E; Schneider J S
Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.
Brain research 2009;1262():109-14.
2009: Schneider J S; Decamp E; Clark K; Bouquio C; Syversen T; Guilarte T R
Effects of chronic manganese exposure on working memory in non-human primates.
Brain research 2009;1258():86-95.
2008: Guilarte Tomás R; Burton Neal C; McGlothan Jennifer L; Verina Tatyana; Zhou Yun; Alexander Mohab; Pham Luu; Griswold Michael; Wong Dean F; Syversen Tore; Schneider Jay S
Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.
Journal of neurochemistry 2008;107(5):1236-47.
2008: Anderson D W; Bradbury K A; Schneider J S
Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
The European journal of neuroscience 2008;28(3):610-7.
2008: Guilarte Tomás R; Burton Neal C; Verina Tatyana; Prabhu Vinaykumar V; Becker Kevin G; Syversen Tore; Schneider Jay S
Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.
Journal of neurochemistry 2008;105(5):1948-59.
2008: McKinney B C; Schneider J S; Schafer G L; Lowing J L; Mohan S; Zhao M X; Heng M Y; Albin R L; Seasholtz A F; Akil H; Murphy G G
Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter.
Genes, brain, and behavior 2008;7(2):203-13.
2008: Kidd S K; Anderson D W; Schneider J S
Postnatal lead exposure alters expression of forebrain p75 and TrkA nerve growth factor receptors.
Brain research 2008;1195():113-9.
2007: Schneider J S; Decamp E
Postnatal lead poisoning impairs behavioral recovery following brain damage.
Neurotoxicology 2007;28(6):1153-7.
2007: Kulak Jennifer M; Fan Hong; Schneider Jay S
Beta2* and beta4* nicotinic acetylcholine receptor expression changes with progressive parkinsonism in non-human primates.
Neurobiology of disease 2007;27(3):312-9.
2007: Aschner Michael; Guilarte Tomás R; Schneider Jay S; Zheng Wei
Manganese: recent advances in understanding its transport and neurotoxicity.
Toxicology and applied pharmacology 2007;221(2):131-47.
2007: Schneider J S
Behavioral persistence deficit in Parkinson's disease patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(3):300-4.
2006: Anderson David W; Bradbury Kristin A; Schneider Jay S
Neuroprotection in Parkinson models varies with toxin administration protocol.
The European journal of neuroscience 2006;24(11):3174-82.
2006: Guilarte Tomás R; McGlothan Jennifer L; Degaonkar Mahaveer; Chen Ming-Kai; Barker Peter B; Syversen Tore; Schneider Jay S
Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study.
Toxicological sciences : an official journal of the Society of Toxicology 2006;94(2):351-8.
2006: Guilarte Tomás R; Chen Ming-Kai; McGlothan Jennifer L; Verina Tatyana; Wong Dean F; Zhou Yun; Alexander Mohab; Rohde Charles A; Syversen Tore; Decamp Emmanuel; Koser Amy Jo; Fritz Stephanie; Gonczi Heather; Anderson David W; Schneider Jay S
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.
Experimental neurology 2006;202(2):381-90.
2006: Schneider Jay S; Decamp Emmanuel; Koser Amy Jo; Fritz Stephanie; Gonczi Heather; Syversen Tore; Guilarte Tomás R
Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates.
Brain research 2006;1118(1):222-31.
2006: Decamp E; Schneider J S
Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.
The European journal of neuroscience 2006;24(7):2098-104.
2006: Schneider J S; Bradbury K A; Anada Yoshihiro; Inokuchi Jin-ichi; Anderson D W
The synthetic ceramide analog L-PDMP partially protects striatal dopamine levels but does not promote dopamine neuron survival in murine models of parkinsonism.
Brain research 2006;1099(1):199-205.
2006: Kulak Jennifer M; Carroll F Ivy; Schneider Jay S
[125I]Iodomethyllycaconitine binds to alpha7 nicotinic acetylcholine receptors in monkey brain.
The European journal of neuroscience 2006;23(10):2604-10.
2006: Lidsky T I; Schneider J S
Adverse effects of childhood lead poisoning: the clinical neuropsychological perspective.
Environmental research 2006;100(2):284-93.
2005: Schneider J S; Anderson D W; Wade T V; Smith M G; Leibrandt P; Zuck L; Lidsky T I
Inhibition of progenitor cell proliferation in the dentate gyrus of rats following post-weaning lead exposure.
Neurotoxicology 2005;26(1):141-5.
2004: Huang Funan; Schneider J S
Effects of lead exposure on proliferation and differentiation of neural stem cells derived from different regions of embryonic rat brain.
Neurotoxicology 2004;25(6):1001-12.
2004: Wade Timothy V; Schneider Jay S
Striatal preprotachykinin gene expression reflects parkinsonian signs.
Neuroreport 2004;15(16):2481-4.
2004: Decamp E; Schneider J S
Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates.
The European journal of neuroscience 2004;20(5):1371-8.
2004: Decamp E; Tinker J P; Schneider J S
Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys.
Behavioural brain research 2004;152(2):259-62.
2004: Kulak Jennifer M; Schneider Jay S
Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.
Brain research 2004;999(2):193-202.
2004: Huang Funan; Vemuri Mohan C; Schneider J S
Modulation of ATP levels alters the mode of hydrogen peroxide-induced cell death in primary cortical cultures: effects of putative neuroprotective agents.
Brain research 2004;997(1):79-88.
2003: Schneider J S; Gonczi Heather; Decamp Emmanuel
Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms.
Brain research 2003;990(1-2):38-44.
2003: Schneider J S; Huang F N; Vemuri M C
Effects of low-level lead exposure on cell survival and neurite length in primary mesencephalic cultures.
Neurotoxicology and teratology 2003;25(5):555-9.
2003: Schneider J S; Tinker J P; Menzaghi F; Lloyd G K
The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
The Journal of pharmacology and experimental therapeutics 2003;306(1):401-6.
2003: Schneider Jay S; Wade Timothy V
Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
Movement disorders : official journal of the Movement Disorder Society 2003;18(1):32-40.
2003: Lidsky Theodore I; Schneider Jay S
Lead neurotoxicity in children: basic mechanisms and clinical correlates.
Brain : a journal of neurology 2003;126(Pt 1):5-19.
2002: Wilson Robert S; Barnes L L; Mendes de Leon C F; Aggarwal N T; Schneider J S; Bach J; Pilat J; Beckett L A; Arnold S E; Evans D A; Bennett D A
Depressive symptoms, cognitive decline, and risk of AD in older persons.
Neurology 2002;59(3):364-70.
2002: Schroeder Joseph A; Schneider Jay S
GABA(A) and mu-opioid receptor binding in the globus pallidus and endopeduncular nucleus of animals symptomatic for and recovered from experimental Parkinsonism.
Brain research 2002;947(2):284-9.
2002: Schroeder J A; Schneider J S
GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion.
Journal of neurochemistry 2002;82(3):666-73.
2002: Schneider J S; Giardiniere M; Morain P
Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):176-82.
2001: Rothblat D S; Schroeder J A; Schneider J S
Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
Journal of neuroscience research 2001;65(3):254-66.
2001: Wade T V; Schneider J S
Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(13):4901-7.
2001: Wade T V; Rothblat D S; Schneider J S
Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism.
Brain research 2001;905(1-2):111-9.
2001: Anderson D W; Neavin T; Smith J A; Schneider J S
Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.
Brain research 2001;905(1-2):44-53.
2001: Schneider J S; Lee M H; Anderson D W; Zuck L; Lidsky T I
Enriched environment during development is protective against lead-induced neurotoxicity.
Brain research 2001;896(1-2):48-55.
2001: Rothblat D S; Rubin E; Schneider J S
Effects of chronic alcohol ingestion on the mesostriatal dopamine system in the rat.
Neuroscience letters 2001;300(2):63-6.
2001: Schroeder J A; Schneider J S
Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental Parkinsonism.
Brain research 2001;888(1):180-183.
2000: Wade T; Rothblat D S; Schneider J S
Changes in striatal dopamine D(2) receptors in relation to expression of and recovery from experimental parkinsonism.
Brain research 2000;871(2):281-7.
2000: Schroeder J A; Schneider J S
Striatal enkephalin gene expression does not reflect parkinsonian signs.
Neuroreport 2000;11(9):1799-802.
2000: Pope-Coleman A; Tinker J P; Schneider J S
Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Synapse (New York, N.Y.) 2000;36(2):120-8.
2000: Mozley P D; Schneider J S; Acton P D; Plössl K; Stern M B; Siderowf A; Leopold N A; Li P Y; Alavi A; Kung H F
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):584-9.
2000: Schneider J S; Tinker J P; Van Velson M; Giardiniere M
Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys.
Brain research 2000;860(1-2):190-4.
1999: Decamp E; Wade T; Schneider J S
Differential regulation of striatal dopamine D(1) and D(2) receptors in acute and chronic parkinsonian monkeys.
Brain research 1999;847(1):134-8.
1999: Schneider J S; Decamp E; Wade T
Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(15):6643-9.
1999: Schneider J S; Tinker J P; Van Velson M; Menzaghi F; Lloyd G K
Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
The Journal of pharmacology and experimental therapeutics 1999;290(2):731-9.
1999: Rothblat D S; Schneider J S
Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study.
Journal of neurochemistry 1999;72(2):724-33.
1999: Tobe E H; Schneider J S; Mrozik T; Lidsky T I
Persisting insomnia following traumatic brain injury.
The Journal of neuropsychiatry and clinical neurosciences 1999;11(4):504-6.
1998: Schneider J S; Schroeder J A; Rothblat D S
Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation.
Brain research 1998;813(1):82-7.
1998: Schneider J S; Pope-Coleman A; Van Velson M; Menzaghi F; Lloyd G K
Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):637-42.
1998: Schneider J S
GM1 ganglioside in the treatment of Parkinson's disease.
Annals of the New York Academy of Sciences 1998;845():363-73.
1998: Rothblat D S; Schneider J S
Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
Annals of the New York Academy of Sciences 1998;845():274-7.
1998: Schneider J S; Roeltgen D P; Mancall E L; Chapas-Crilly J; Rothblat D S; Tatarian G T
Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study.
Neurology 1998;50(6):1630-6.
1998: Schneider J S; Tobe E H; Mozley P D; Barniskis L; Lidsky T I
Persistent cognitive and motor deficits following acute hydrogen sulphide poisoning.
Occupational medicine (Oxford, England) 1998;48(4):255-60.
1998: Schneider J S; Van Velson M; Menzaghi F; Lloyd G K
Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment.
Annals of neurology 1998;43(3):311-7.
1998: Schneider J S; Wade T; Lidsky T I
Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum.
Neuroreport 1998;9(1):133-6.
1998: Rothblat D S; Schneider J S
The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
Brain research 1998;779(1-2):226-30.
1998: Schneider J S; Peacock V
Differential effects of GDNF treatment on rotational asymmetry, skilled forelimb use deficits and sensory neglect in unilateral 6-OHDA-lesioned rats.
Restorative neurology and neuroscience 1998;13(3-4):205-12.
1997: Rothblat D S; Schneider J S
Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
Neuroscience letters 1997;228(2):119-22.
1997: Brown L L; Schneider J S; Lidsky T I
Sensory and cognitive functions of the basal ganglia.
Current opinion in neurobiology 1997;7(2):157-63.
1997: Rioux L; Frohna P A; Joyce J N; Schneider J S
The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Movement disorders : official journal of the Movement Disorder Society 1997;12(2):148-58.
1997: Schneider J S
Preservation of autoreceptor-mediated increases in dopamine synthesis in aged mice with experimentally-induced parkinsonism.
Neuroscience letters 1997;222(2):138-40.
1996: Schneider J S; Rothblat D S
Alterations in intralaminar and motor thalamic physiology following nigrostriatal dopamine depletion.
Brain research 1996;742(1-2):25-33.
1995: Rothblat D S; Schneider J S
Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats.
Brain research 1995;705(1-2):1-14.
1995: Schneider J S; Pope-Coleman A
Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(3):245-55.
1995: Schneider J S; Kean A; DiStefano L
GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
Journal of neuroscience research 1995;42(1):117-23.
1995: Johnson B J; Peacock V; Schneider J S
Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
Pharmacology, biochemistry, and behavior 1995;51(4):617-22.
1995: Lidsky T I; Schneider J S; Yablonsky-Alter E; Zuck L G; Banerjee S P
Taurine prevents haloperidol-induced changes in striatal neurochemistry and behavior.
Brain research 1995;686(1):104-6.
1995: Schneider J S; Roeltgen D P; Rothblat D S; Chapas-Crilly J; Seraydarian L; Rao J
GM1 ganglioside treatment of Parkinson's disease: an open pilot study of safety and efficacy.
Neurology 1995;45(6):1149-54.
1995: Schneider J S; Distefano L
Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion.
Neuropharmacology 1995;34(5):489-93.
1995: Schneider J S; DiStefano L
Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments.
Brain research 1995;674(2):260-4.
1995: Rothblat D S; Schneider J S
Repeated exposure to MPTP does not produce a permanent movement disorder in cats recovered from MPTP-induced parkinsonism.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(1):87-92.
1995: Schneider J S; Lidsky T I; Hawks T; Mazziotta J C; Hoffman J M
Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
Brain research 1995;672(1-2):112-7.
1995: Frohna P A; Rothblat D S; Joyce J N; Schneider J S
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Synapse (New York, N.Y.) 1995;19(1):46-55.
1994: Schneider J S; Sun Z Q; Roeltgen D P
Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
Brain research 1994;663(1):140-4.
1994: Lidsky T I; Schneider J S
Effects of experience on striatal sensory responses.
Neuroscience letters 1994;174(2):141-4.
1994: Schneider J S; Sun Z Q; Roeltgen D P
Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.
Pharmacology, biochemistry, and behavior 1994;48(1):235-40.
1994: Schneider J S; DiStefano L
Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism.
Neurology 1994;44(4):748-50.
1994: Schneider J S; Rothblat D S; DiStefano L
Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism.
Brain research 1994;643(1-2):86-91.
1994: Stull N D; Schneider J S; Iacovitti L
GM1 ganglioside partially rescues cultured dopaminergic neurons from MPP(+)-induced damage: dependence on initial damage and time of treatment.
Brain research 1994;640(1-2):308-15.
1994: Roeltgen D P; Schneider J S
Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys.
Behavioural brain research 1994;60(2):115-24.
1994: Schneider J S; Smith M G; DiStefano L; Berrian J
GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse.
Brain research 1994;636(2):353-6.
1994: Rothblat D S; Schneider J S
Spontaneous functional recovery from parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons.
Brain research bulletin 1994;34(3):309-12.
1993: Schneider J S; DiStefano L
LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
Neuroreport 1993;5(2):103-4.
1993: Rothblat D S; Schneider J S
Response of caudate neurons to stimulation of intrinsic and peripheral afferents in normal, symptomatic, and recovered MPTP-treated cats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1993;13(10):4372-8.
1993: Schneider J S; Roeltgen D P
Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys.
Brain research 1993;615(2):351-4.
1993: Schneider J S; Roeltgen D P
Gangliosides and neurological diseases.
BMJ (Clinical research ed.) 1993;306(6871):204.
1992: Schneider J S; McLaughlin W W; Roeltgen D P
Motor and nonmotor behavioral deficits in monkeys made hemiparkinsonian by intracarotid MPTP infusion.
Neurology 1992;42(8):1565-72.
1992: Schneider J S; Pope A; Simpson K; Taggart J; Smith M G; DiStefano L
Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
Science (New York, N.Y.) 1992;256(5058):843-6.
1992: Schneider J S
Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Neuropharmacology 1992;31(2):185-92.
1992: Schneider J S
MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Journal of neuroscience research 1992;31(1):112-9.
1991: Schneider J S; Dacko S
Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
Brain research 1991;556(2):292-6.
1991: Dacko S; Schneider J S
Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms.
Neuroscience letters 1991;127(1):49-52.
1991: Schneider J S
Responses of striatal neurons to peripheral sensory stimulation in symptomatic MPTP-exposed cats.
Brain research 1991;544(2):297-302.
1991: Melega W P; Hoffman J M; Schneider J S; Phelps M E; Barrio J R
6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography.
Brain research 1991;543(2):271-6.
1991: Lin C S; Nicolelis M A; Schneider J S; Chapin J K
GABAergic pathway from zona incerta to neocortex: clarification.
Science (New York, N.Y.) 1991;251(4998):1162.
1991: Roeltgen D P; Schneider J S
Chronic low-dose MPTP in nonhuman primates: a possible model for attention deficit disorder.
Journal of child neurology 1991;6 Suppl():S82-9.
1991: Schneider J S; Rothblat D S
Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats.
Neuroscience 1991;44(2):421-9.
1990: Barrio J R; Huang S C; Melega W P; Yu D C; Hoffman J M; Schneider J S; Satyamurthy N; Mazziotta J C; Phelps M E
6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
Journal of neuroscience research 1990;27(4):487-93.
1990: Schneider J S
Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys.
Brain research 1990;534(1-2):25-36.
1990: Schneider J S; Kovelowski C J
Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.
Brain research 1990;519(1-2):122-8.
1990: Lin C S; Nicolelis M A; Schneider J S; Chapin J K
A major direct GABAergic pathway from zona incerta to neocortex.
Science (New York, N.Y.) 1990;248(4962):1553-6.
1989: Ohgaki T; Markham C H; Schneider J S; Curthoys I S
Anatomical evidence of the projection of pontine omnipause neurons to midbrain regions controlling vertical eye movements.
The Journal of comparative neurology 1989;289(4):610-25.
1989: Schneider J S
Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage.
Pharmacology, biochemistry, and behavior 1989;34(1):193-6.
1989: Schneider J S; Yuwiler A
GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
Experimental neurology 1989;105(2):177-83.
1989: Williams J L; Schneider J S
MPTP-induced ventral mesencephalic cell loss in the cat.
Neuroscience letters 1989;101(3):258-62.
1988: Schneider J S; Unguez G; Yuwiler A; Berg S C; Markham C H
Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Brain : a journal of neurology 1988;111 ( Pt 6)():1265-85.
1988: Unguez G A; Schneider J S
Dopaminergic dorsal raphe neurons in cats and monkeys are sensitive to the toxic effects of MPTP.
Neuroscience letters 1988;94(1-2):218-23.
1988: Schneider J S; Denaro F J
Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
Journal of neuropathology and experimental neurology 1988;47(4):452-8.
1987: Schneider J S; Markham C H
Immunohistochemical localization of monoamine oxidase-B in the cat brain: clues to understanding N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity.
Experimental neurology 1987;97(3):465-81.
1987: Schneider J S; Diamond S G; Markham C H
Parkinson's disease: sensory and motor problems in arms and hands.
Neurology 1987;37(6):951-6.
1987: Schneider J S; Yuwiler A; Markham C H
Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
Brain research 1987;411(1):144-50.
1987: Levine M S; Schneider J S; Lloyd R L; Hull C D; Buchwald N A
Aging reduces somatosensory responsiveness of caudate neurons in the awake cat.
Brain research 1987;405(2):389-94.
1987: Schneider J S
Ingestion-related activity of caudate and entopeduncular neurons in the cat.
Experimental neurology 1987;95(1):216-23.
1987: Diamond S G; Schneider J S; Markham C H
Oral sensorimotor defects in patients with Parkinson's disease.
Advances in neurology 1987;45():335-8.
1986: Schneider J S
Interactions between the basal ganglia, the pontine parabrachial region, and the trigeminal system in cat.
Neuroscience 1986;19(2):411-25.
1986: Schneider J S; Markham C H
Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.
Brain research 1986;373(1-2):258-67.
1986: Schneider J S; Diamond S G; Markham C H
Deficits in orofacial sensorimotor function in Parkinson's disease.
Annals of neurology 1986;19(3):275-82.
1986: Schneider J S; Yuwiler A; Markham C H
Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.
Experimental neurology 1986;91(2):293-307.
1985: Schneider J S; Manetto C; Lidsky T I
Substantia nigra projection to medullary reticular formation: relevance to oculomotor and related motor functions in the cat.
Neuroscience letters 1985;62(1):1-6.
1985: Schneider J S; Levine M S; Hull C D; Buchwald N A
Development of somatosensory responsiveness in the basal ganglia in awake cats.
Journal of neurophysiology 1985;54(1):143-54.
1985: Lidsky T I; Manetto C; Schneider J S
A consideration of sensory factors involved in motor functions of the basal ganglia.
Brain research 1985;356(2):133-46.
1984: Schneider J S
Basal ganglia role in behavior: importance of sensory gating and its relevance to psychiatry.
Biological psychiatry 1984;19(12):1693-710.
1984: Schneider J S; Olazabal U E
Behaviorally specific limb use deficits following globus pallidus lesions in rats.
Brain research 1984;308(2):341-6.
1984: Schneider J S
Role of the basal ganglia in a chemically induced dyskinesia in rat.
Experimental neurology 1984;84(3):524-32.
1984: Schneider J S; Levine M S; Hull C D; Buchwald N A
Effects of amphetamine on intracellular responses of caudate neurons in the cat.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1984;4(4):930-8.
1984: Schneider J S
Motor function of basal ganglia.
Neurology 1984;34(2):262-3.
1983: Schneider J S; Wilson J S; Hull C D; Buchwald N A
Intracellular responses of caudate neurons to stimulation of cortex and substantia nigra following large thalamic lesions.
Brain research 1983;265(2):322-7.
1982: Schneider J S; Denaro F J; Lidsky T I
Basal ganglia: motor influences mediated by sensory interactions.
Experimental neurology 1982;77(3):534-43.
1982: Schneider J S; Castaldi A A; Lidsky T I
A device enabling single unit recordings during head movements in cats.
Brain research bulletin 1982;8(4):443-4.
1982: Schneider J S; Morse J R; Lidsky T I
Somatosensory properties of globus pallidus neurons in awake cats.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1982;46(2):311-4.
1981: Lidsky T I; Schneider J S
Neural mechanisms of tardive dyskinesia.
Medical hypotheses 1981;7(9):1117-22.
1981: Schneider J S; Denaro F J; Olazabal U E; Leard H O
Stereotaxic atlas of the trigeminal ganglion in rat, cat, and monkey.
Brain research bulletin 1981;7(1):93-5.
1981: Schneider J S; Lidsky T I
Processing of somatosensory information in striatum of behaving cats.
Journal of neurophysiology 1981;45(5):841-51.
1981: Kramer D M; Schneider J S; Rudin A M; Lauterbur P C
True three-dimensional nuclear magnetic resonance zeugmatographic images of a human brain.
Neuroradiology 1981;21(5):239-44.
1980: Lidsky T I; Schneider J S; Harper J A
Jaw movements evoked by substantia nigra stimulation: role of extranigral current spread.
Brain research bulletin 1980;5(4):487-9.

Sign-in to see more